Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Experience Profiling of Fluorescence-Guided Surgery I: Gliomas.

Ji SY, Kim JW, Park CK.

Brain Tumor Res Treat. 2019 Oct;7(2):98-104. doi: 10.14791/btrt.2019.7.e38.

2.

Experience Profiling of Fluorescence-Guided Surgery II: Non-Glioma Pathologies.

Ji SY, Kim JW, Park CK.

Brain Tumor Res Treat. 2019 Oct;7(2):105-111. doi: 10.14791/btrt.2019.7.e39.

3.

Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma.

Tsugu A, Ishizaka H, Mizokami Y, Osada T, Baba T, Yoshiyama M, Nishiyama J, Matsumae M.

World Neurosurg. 2011 Jul-Aug;76(1-2):120-7. doi: 10.1016/j.wneu.2011.02.005.

PMID:
21839963
4.

A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.

Lau D, Hervey-Jumper SL, Chang S, Molinaro AM, McDermott MW, Phillips JJ, Berger MS.

J Neurosurg. 2016 May;124(5):1300-9. doi: 10.3171/2015.5.JNS1577. Epub 2015 Nov 6.

PMID:
26544781
5.

Identification of PEPT2 as an important candidate molecule in 5-ALA-mediated fluorescence-guided surgery in WHO grade II/III gliomas.

Hou C, Yamaguchi S, Ishi Y, Terasaka S, Kobayashi H, Motegi H, Hatanaka KC, Houkin K.

J Neurooncol. 2019 Jun;143(2):197-206. doi: 10.1007/s11060-019-03158-3. Epub 2019 Mar 30.

PMID:
30929128
6.

Finding the anaplastic focus in diffuse gliomas: the value of Gd-DTPA enhanced MRI, FET-PET, and intraoperative, ALA-derived tissue fluorescence.

Ewelt C, Floeth FW, Felsberg J, Steiger HJ, Sabel M, Langen KJ, Stoffels G, Stummer W.

Clin Neurol Neurosurg. 2011 Sep;113(7):541-7. doi: 10.1016/j.clineuro.2011.03.008. Epub 2011 Apr 20.

PMID:
21507562
7.

What is the Surgical Benefit of Utilizing 5-Aminolevulinic Acid for Fluorescence-Guided Surgery of Malignant Gliomas?

Hadjipanayis CG, Widhalm G, Stummer W.

Neurosurgery. 2015 Nov;77(5):663-73. doi: 10.1227/NEU.0000000000000929. Review.

8.

Fluorescence-guided surgery in high grade gliomas using an exoscope system.

Belloch JP, Rovira V, Llácer JL, Riesgo PA, Cremades A.

Acta Neurochir (Wien). 2014 Apr;156(4):653-60. doi: 10.1007/s00701-013-1976-6. Epub 2014 Jan 28.

PMID:
24468884
9.

Impact of 5-aminolevulinic acid fluorescence-guided surgery on the extent of resection of meningiomas--with special regard to high-grade tumors.

Cornelius JF, Slotty PJ, Kamp MA, Schneiderhan TM, Steiger HJ, El-Khatib M.

Photodiagnosis Photodyn Ther. 2014 Dec;11(4):481-90. doi: 10.1016/j.pdpdt.2014.07.008. Epub 2014 Aug 10.

PMID:
25117928
10.

The impact of fluorescence guidance on spinal intradural tumour surgery.

Eicker SO, Floeth FW, Kamp M, Steiger HJ, Hänggi D.

Eur Spine J. 2013 Jun;22(6):1394-401. doi: 10.1007/s00586-013-2657-0. Epub 2013 Jan 10.

11.

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of brain tumors in children--a technical report.

Beez T, Sarikaya-Seiwert S, Steiger HJ, Hänggi D.

Acta Neurochir (Wien). 2014 Mar;156(3):597-604. doi: 10.1007/s00701-014-1997-9. Epub 2014 Jan 22.

PMID:
24449149
12.

5-Aminolevulinic acid fluorescence guided surgery for recurrent high-grade gliomas.

Chohan MO, Berger MS.

J Neurooncol. 2019 Feb;141(3):517-522. doi: 10.1007/s11060-018-2956-8. Epub 2018 Aug 10. Review.

PMID:
30097823
13.

Established and emerging uses of 5-ALA in the brain: an overview.

Díez Valle R, Hadjipanayis CG, Stummer W.

J Neurooncol. 2019 Feb;141(3):487-494. doi: 10.1007/s11060-018-03087-7. Epub 2019 Jan 3. Review.

PMID:
30607705
14.

5-Aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhancement.

Widhalm G, Wolfsberger S, Minchev G, Woehrer A, Krssak M, Czech T, Prayer D, Asenbaum S, Hainfellner JA, Knosp E.

Cancer. 2010 Mar 15;116(6):1545-52. doi: 10.1002/cncr.24903.

15.
16.

Quantitative fluorescence using 5-aminolevulinic acid-induced protoporphyrin IX biomarker as a surgical adjunct in low-grade glioma surgery.

Valdés PA, Jacobs V, Harris BT, Wilson BC, Leblond F, Paulsen KD, Roberts DW.

J Neurosurg. 2015 Sep;123(3):771-80. doi: 10.3171/2014.12.JNS14391. Epub 2015 Jul 3.

17.

Analysis of 5-aminolevulinic acid-induced fluorescence in 55 different spinal tumors.

Millesi M, Kiesel B, Woehrer A, Hainfellner JA, Novak K, Martínez-Moreno M, Wolfsberger S, Knosp E, Widhalm G.

Neurosurg Focus. 2014 Feb;36(2):E11. doi: 10.3171/2013.12.FOCUS13485.

PMID:
24484249
18.

Genetic Factors Affecting Intraoperative 5-aminolevulinic Acid-induced Fluorescence of Diffuse Gliomas.

Saito K, Hirai T, Takeshima H, Kadota Y, Yamashita S, Ivanova A, Yokogami K.

Radiol Oncol. 2017 Apr 12;51(2):142-150. doi: 10.1515/raon-2017-0019. eCollection 2017 Jun.

19.

Use of fluorescence to guide resection or biopsy of primary brain tumors and brain metastases.

Marbacher S, Klinger E, Schwyzer L, Fischer I, Nevzati E, Diepers M, Roelcke U, Fathi AR, Coluccia D, Fandino J.

Neurosurg Focus. 2014 Feb;36(2):E10. doi: 10.3171/2013.12.FOCUS13464.

PMID:
24484248
20.

The Value of 5-Aminolevulinic Acid in Low-grade Gliomas and High-grade Gliomas Lacking Glioblastoma Imaging Features: An Analysis Based on Fluorescence, Magnetic Resonance Imaging, 18F-Fluoroethyl Tyrosine Positron Emission Tomography, and Tumor Molecular Factors.

Jaber M, Wölfer J, Ewelt C, Holling M, Hasselblatt M, Niederstadt T, Zoubi T, Weckesser M, Stummer W.

Neurosurgery. 2016 Mar;78(3):401-11; discussion 411. doi: 10.1227/NEU.0000000000001020.

Supplemental Content

Support Center